| Attributes | Values |
|---|
| rdf:type
| |
| description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в січні 1998 (uk)
- articolo scientifico (pubblicato il 1998) (it)
- article scientifique publié en 1998 (fr)
- im Januar 1998 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en xineru de 1998 (ast)
- scientific article published on 01 January 1998 (en)
- artikull shkencor i botuar më 01 janar 1998 (sq)
|
| publication date
| |
| publication date
| |
| author name string
| |
| author name string
| - L A García Rodríguez
- C Cattaruzzi
- L Agostinis
- M G Troncon
|
| rdfs:label
| - Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (en)
- Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (nl)
- Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (sq)
|
| skos:prefLabel
| - Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (en)
- Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (nl)
- Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (sq)
|
| name
| - Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (en)
- Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (nl)
- Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (sq)
|
| title
| |
| title
| - Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| number of pages
| |
| number of pages
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.1001/ARCHINTE.158.1.33
|
| is about
of | |
| is cites work
of | - Aspirin: new cardiovascular uses for an old drug
- Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study
- Study on drug related hospital admissions in a tertiary care hospital in South India
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis
- Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement
- Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies
- Cyclo-oxygenase-1/cyclo-oxygenase-2 non selective non-steroidal anti-inflammatory drugs: epidemiology of gastrointestinal events
- Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study
- Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs).
- Gastrointestinal effects of NSAIDs and coxibs
- The iatrogenic costs of NSAID therapy: a population study
- Use of the UK General Practice Research Database for pharmacoepidemiology
- Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs
- Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies
- COX-2 inhibitors
- Intravenous analgesia
- Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review
- Over-the-counter analgesics in older adults: a call for improved labelling and consumer education
- Co-morbidity in rheumatoid arthritis
- Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis
- Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
- Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients
- Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors
- Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease
- Risk of hospitalization for upper gastrointestinal tract bleeding
- A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis
- Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs
- Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)
- Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings.
- COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?
- Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach
- Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
- Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs
- Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.
- Thromboxane and the thromboxane receptor in cardiovascular disease
- Minimising the adverse effects of ketorolac
- Adverse effects of nonsteroidal anti-inflammatory drugs on the colon
- Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.
- Comorbidity in rheumatoid arthritis.
- Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract
- Safety profiles of leading nonsteroidal anti-inflammatory drugs.
- Characteristics and outcomes of acute upper gastrointestinal bleeding after therapeutic endoscopy in the elderly
- Dihydropyridine calcium channel antagonists in the management of hypertension
- Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
- [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects]
- A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis.
- [Demand for dispensing of medicines without medical prescription].
- Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs
- Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database
- The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents
- An evidence-based update on nonsteroidal anti-inflammatory drugs
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)